RJ Hamster
🌎 Marvell Technology Upgraded, BioMarin Pharmaceutical Downgraded, CSW Industrials…
| Ratings changes for Marvell Technology, Marvell Technology, CrowdStrike, CrowdStrike, CrowdStrike, Academy Sports and Outdoors, Marvell Technology and more…Upgrade to MarketBeat All Access to get our best stock ideas, proprietary research, portfolio monitoring tools, and more. Start Your Free Trial.Unsubscribe.VIEW MY PORTFOLIODECEMBER 3RD, 2025You’ve Got to See This Pattern Before 2025 Picks Up… (ad)Your Access to Private Market Briefings Begins Here Stock Wire News delivers select early alerts typically seen only by advanced traders. These briefings focus on speed, clarity, and high-urgency setups. JOIN FREE — SEE TODAY’S PRIVATE BRIEFINGToday’s Top StoriesPalantir Stock Finds Its Footing—and a Path to Global GrowthBY CHRIS MARKOCH | DECEMBER 3, 2025 07:20 AMWhy one “gap trade” a day could replace your job (Ad)BY BASE CAMP TRADINGWall Street’s Sleeping Giant: Is Amazon About to Wake Up?BY SAM QUIRKE | DECEMBER 2, 2025 05:29 PMWorried About Mag 7 Concentration Risk? This ETF Could HelpBY LEO MILLER | DECEMBER 2, 2025 03:16 PMThe Next Digital Currency Cycle Is Already Starting (Ad)BY DARWINNVIDIA’s $2B Power Play: Securing the Future of Chip DesignBY JEFFREY NEAL JOHNSON | DECEMBER 2, 2025 11:12 AMInsiders Swarm Vertical Aerospace Stock Ahead of Make-or-Break RevealBY JEFFREY NEAL JOHNSON | DECEMBER 2, 2025 10:18 AMQuick LinksAnalyst RatingsMy MarketBeatAccount SettingsMarketBeat All AccessStock ListsStock ScreenerCalculatorsPremium ReportsBest Stocks to Buy in DecemberTrump’s Policies Are Shifting the Market—Here’s How to Play It (ad)Trump is back in the White House—and new market winners are already emerging. A free report reveals 5 stocks poised to benefit from early policy shifts, sector momentum, and the evolving 2025 economy. DOWNLOAD YOUR FREE REPORT: 5 BEST STOCKS FOR TRUMP’S AMERICAYour WatchlistMANAGE YOUR WATCHLIST AND MONITOR YOUR PORTFOLIO Apple Inc. (AAPL) $287.91 +1.72 (+0.60%) As of 12/3/2025 9:46 AM ETTriglav Investments D.O.O. Trims Holdings in Apple Inc. $AAPL 12/3 – MARKETBEATWelch & Forbes LLC Reduces Holdings in Apple Inc. $AAPL 12/3 – MARKETBEATIntel (INTC) Stock Gains on Malaysia Expansion and Potential Apple Deal 12/3 – BLOCKONOMIApple (AAPL) Gains Analyst Confidence as iPhone 17 Lead Times Rise Ahead of Holiday Season 12/3 – MSNiPhone 17 will drive record Apple shipments in 2025, IDC says 12/3 – CNBC Amazon.com, Inc. (AMZN) $231.76 -2.66 (-1.13%) As of 12/3/2025 9:46 AM ETAmazon stock rating reiterated by Cantor Fitzgerald following AWS re:Invent announcements 12/3 – INVESTINGNetflix Goes All In: The $70B Play to End the Streaming Wars (AMZN) 12/3 – MARKETBEATWaverton Investment Management Ltd Has $421.41 Million Holdings in Amazon.com, Inc. $AMZN 12/3 – MARKETBEATAmazon Stock (NASDAQ: AMZN) Price Prediction and Forecast 2025-2030 for December 3 12/3 – 247WALLSTNvidia Stock Gains. It Has This Key Advantage Over Amazon’s New AI Chips. 12/3 – BARRONS Alphabet Inc. (GOOGL) $315.46 -0.35 (-0.11%) As of 12/3/2025 9:46 AM ETCAO Amie Thuener O’toole sold 954 shares of the stock in a transaction on Tuesday, December 2nd. The stock was sold at an average price of $317.00, for a total transaction of $302,418.00. Following the completion of the sale, the chief accounting officer directly owned 11,740 shares in the company, valued at approximately $3,721,580. This trade represents a 7.52% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Director Frances Arnold sold 102 shares of Alphabet stock in a transaction on Monday, December 1st. The stock was sold at an average price of $317.66, for a total transaction of $32,401.32. Following the completion of the sale, the director owned 18,104 shares of the company’s stock, valued at approximately $5,750,916.64. This trade represents a 0.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Google’s Chinese Rival Hits Growth Roadblock Amid Mass Layoffs After Disappointing Q3 12/3 – BENZINGANvidia’s Fat Margins Are Google and AMD’s Opportunity 12/3 – WSJJourney Strategic Wealth LLC Purchases 17,098 Shares of Alphabet Inc. $GOOGL 12/3 – MARKETBEATAlphabet Inc. $GOOGL is Mediolanum International Funds Ltd’s 7th Largest Position 12/3 – MARKETBEATBloomsbury gains after unveiling AI partnership with Google Cloud 12/3 – PROACTIVEINVESTORS Meta Platforms, Inc. (META) $646.09 -1.01 (-0.16%) As of 12/3/2025 9:46 AM ETMeta Platforms, Inc. $META Shares Purchased by Waterloo Capital L.P. 12/3 – MARKETBEATVestor Capital LLC Sells 102,761 Shares of Meta Platforms, Inc. $META 12/3 – MARKETBEATMeta Platforms (NASDAQ: META) Price Prediction and Forecast 2025-2030 for December 3 12/3 – 247WALLSTMeta is fighting Florida’s lawsuit targeting Facebook and Instagram 12/2 – WLRNMark Zuckerberg’s Instagram orders workers back to office 5 days per week 12/2 – NYPOST Microsoft Corporation (MSFT) $476.90 -13.10 (-2.67%) As of 12/3/2025 9:46 AM ETMicrosoft Corporation (NASDAQ:MSFT) announced a quarterly dividend on Tuesday, December 2nd. Shareholders of record on Thursday, February 19th will be paid a dividend of 0.91 per share by the software giant on Thursday, March 12th. This represents a c) annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Thursday, February 19th. Michael Saylor Says Bitcoin’s Trading Power Exceeds Google, Microsoft – Even The US Navy’s Annual Spending 12/3 – MSNMicrosoft stock falls after report of lowered AI sales quotas 12/3 – INVESTINGMicrosoft lowers AI software sales quota as customers resist new products, The Information reports 12/3 – REUTERSClaude AI Maker Anthropic Takes Major Step Toward $300 Billion IPO 12/3 – BLOCKONOMIMSFO: Collecting Income From Microsoft’s Volatility 12/3 – SEEKINGALPHA MANAGE YOUR WATCHLIST Analysts’ UpgradesAmerican Eagle Outfitters (NYSE:AEO) was upgraded by analysts at JPMorgan Chase & Co. from an “underweight” rating to a “neutral” rating. They now have a $20.00 price target on the stock, up previously from $14.00. This represents a 16.3% downside from the current price of $23.89.Bayer Aktiengesellschaft (OTCMKTS:BAYRY) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating.The current price is $9.82.BW LPG (NYSE:BWLP) was upgraded by analysts at Clarkson Capital from a “neutral” rating to a “buy” rating.The current price is $12.45.CSW Industrials (NYSE:CSW) was upgraded by analysts at JPMorgan Chase & Co. from a “neutral” rating to an “overweight” rating. They now have a $350.00 price target on the stock, up previously from $300.00. This represents a 19.6% upside from the current price of $292.54.Garmin (NYSE:GRMN) was upgraded by analysts at Longbow Research from a “neutral” rating to a “buy” rating. They now have a $250.00 price target on the stock. This represents a 24.3% upside from the current price of $201.12.Lyft (NASDAQ:LYFT) was upgraded by analysts at Arete from a “sell” rating to a “neutral” rating. They now have a $20.00 price target on the stock. This represents a 11.0% downside from the current price of $22.47.Marvell Technology (NASDAQ:MRVL) was upgraded by analysts at Summit Insights from a “hold” rating to a “buy” rating.The current price is $99.51.PennantPark Investment (NASDAQ:PNNT) was upgraded by analysts at Compass Point from a “sell” rating to a “neutral” rating. They now have a $5.50 price target on the stock, down previously from $5.75. This represents a 3.9% downside from the current price of $5.73.Spruce Biosciences (NASDAQ:SPRB) was upgraded by analysts at Leerink Partners from a “market perform” rating to an “outperform” rating. They now have a $160.00 price target on the stock. This represents a 70.9% upside from the current price of $93.65.Uber Technologies (NYSE:UBER) was upgraded by analysts at Arete from a “neutral” rating to a “buy” rating. They now have a $125.00 price target on the stock. This represents a 37.5% upside from the current price of $90.90.Vertex Pharmaceuticals (NASDAQ:VRTX) was upgraded by analysts at Morgan Stanley from an “equal weight” rating to an “overweight” rating. They now have a $516.00 price target on the stock. This represents a 13.6% upside from the current price of $454.03.Essential Utilities (NYSE:WTRG) was upgraded by analysts at Northcoast Research from a “neutral” rating to a “buy” rating. They now have a $42.00 price target on the stock. This represents a 6.7% upside from the current price of $39.36. VIEW MORE UPGRADES Our Pressure-Point Scan Flagged These Tickers Today (ad)See Where Market Pressure Is Building First Market Crux tracks inflection zones and early tension points across small caps. These signals often appear before the first fast move. GET FREE ALERTS — FOLLOW THE PRESSURE POINTSAnalysts’ DowngradesAcadia Healthcare (NASDAQ:ACHC) was downgraded by analysts at Bank of America Corporation from a “neutral” rating to an “underperform” rating. They now have a $13.00 price target on the stock, down previously from $21.50. This represents a 6.9% downside from the current price of $13.97.BioMarin Pharmaceutical (NASDAQ:BMRN) was downgraded by analysts at Leerink Partners from an “outperform” rating to a “market perform” rating. They now have a $60.00 price target on the stock, down previously from $82.00. This represents a 11.2% upside from the current price of $53.98.Regeneron Pharmaceuticals (NASDAQ:REGN) was downgraded by analysts at Morgan Stanley from an “overweight” rating to an “equal weight” rating. They now have a $767.00 price target on the stock. This represents a 3.3% upside from the current price of $742.50. VIEW MORE DOWNGRADES Why one “gap trade” a day could replace your job (ad)Some of Wall Street’s biggest players have been taking advantage of the same early-morning price behavior for years — a pattern that appears shortly after the opening bell when overnight institutional flows hit the market. Most retail traders never notice it, but Dave Aquino has spent years studying this window and developed a simple routine built to capitalize on it without relying on news or predictions. He calls it the Good Morning Cash Plan — a single morning setup designed to give traders a structured, rules-based approach before the day even begins. Dave breaks down the full method in a free training session, including how he identifies the setup each morning. WATCH THE GOOD MORNING CASH PLAN TRAINING HEREAnalysts’ New CoverageCompass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Canaccord Genuity Group Inc.. They set a “buy” rating and a $10.00 price target on the stock. This represents a 88.0% upside from the current price of $5.32.Compass Therapeutics (NASDAQ:CMPX) is now covered by analysts at Citizens Jmp. They set an “outperform” rating and a $10.00 price target on the stock. This represents a 88.0% upside from the current price of $5.32.Honeywell International (NASDAQ:HON) is now covered by analysts at BNP Paribas Exane. They set a “neutral” rating and a $195.00 price target on the stock. This represents a 0.1% upside from the current price of $194.82.Oculis (NASDAQ:OCS) is now covered by analysts at Lifesci Capital. They set an “outperform” rating and a $55.00 price target on the stock. This represents a 191.4% upside from the current price of $18.88.Pitney Bowes (NYSE:PBI) is now covered by analysts at Citizens Jmp. They set an “outperform” rating and a $13.00 price target on the stock. This represents a 30.1% upside from the current price of $9.99.Palatin Technologies (NYSEAMERICAN:PTN) is now covered by analysts at Alliance Global Partners. They set a “buy” rating and a $50.00 price target on the stock. This represents a 168.1% upside from the current price of $18.65.Zymeworks (NYSE:ZYME) is now covered by analysts at Citizens Jmp. They set an “outperform” rating and a $32.00 price target on the stock. This represents a 25.0% upside from the current price of $25.60. VIEW MORE NEW COVERAGE Calendars from MarketBeatU.S. Analyst RatingsCongressional BuyingCorporate BuybacksCryptocurrenciesDividend DeclarationsEarnings AnnouncementsEarnings Conference CallsFDA CalendarGap Up/Down StocksInsider TradesInitial Public Offerings (IPOs)Most Active StocksPercentage Gainers/DeclinersSector PerformanceShort InterestStock SplitsUnusual Options VolumeUnusual Trading VolumeGET 30 DAYS OF MARKETBEAT ALL ACCESS FREESign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:Best-in-Class Portfolio MonitoringView the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.Stock Ideas and RecommendationsGet daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.Advanced Stock Screeners and Research ToolsIdentify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis. START YOUR 30-DAY FREE TRIAL  Thank you for subscribing to MarketBeat!MarketBeat empowers investors to make better trading decisions by offering up-to-the-minute financial information and objective investment research.If you have questions about your newsletter, please feel free to email MarketBeat’s South Dakota based support team at contact@marketbeat.com. If you wish to opt out or modify which emails you subscribe to, you can update your subscription preferences or unsubscribe from these emails. © 2006-2025 MarketBeat Media, LLC. All rights protected. 345 North Reid Place #620, Sioux Falls, S.D. 57103. United States of America..Just For You: Buy. Hold. Relax. These 10 Stocks Could Build Your 2030 Wealth (Click to Opt-In) |
